Artelo Biosciences Inc

Research Artelo Biosciences Inc (ARTL) on Bullrun: market cap USD 2.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerARTL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.57M
• Financial periodFY2025
• Net income-USD 12.88M

Valuation Snapshot

latest market cap is USD 2.57M.

About Artelo Biosciences Inc

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia;

Frequently asked questions

What is Artelo Biosciences Inc's market cap?

Artelo Biosciences Inc's market capitalization is USD 2.57M.

What does Artelo Biosciences Inc do?

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.